Contribution of immunohistochemical (IHC) markers to the diagnosis of pulmonary carcinoids Source: Annual Congress 2011 - Lung cancer: molecular pathology and functional genomics Year: 2011
Prognostic impact of nestin expression in resected large cell neuroendocrine carcinoma of the lung Source: Annual Congress 2012 - Prognosis of lung cancer Year: 2012
Correlation of p53, EGFR and HER2 expression in the diagnostic biopsies and the corresponding resected tumours in NSCLC Source: Eur Respir J 2003; 22: Suppl. 45, 198s Year: 2003
Prognostic impact of histologic demonstration of chromogranin A and neuron specific enolase in pulmonary adenocarcinoma Source: Eur Respir J 2007; 30: Suppl. 51, 290s Year: 2007
The prognostic significance of circulating neuroendocrine markers chromogranin A, pro-gastrin-releasing peptide and neuron- specific enolase in patients with advanced non-small-cell lung cancer Source: Annual Congress 2010 - Biomarkers for lung cancer Year: 2010
Correlation of P53 and CerbB-2 expression in the diagnostic biopsies and the corresponding resected tumors in non small cell lung caner Source: Eur Respir J 2004; 24: Suppl. 48, 43s Year: 2004
Expression of caveolin-1 and ttf-1 in lung adenocarcinomas with various histological subtypes Source: Annual Congress 2009 - Lung cancer biology Year: 2009
An immunohistochemistry (IHC) assessemnt of NSCLC cases Source: Annual Congress 2008 - Novel mechanisms and targets of molecular pulmonary pathology Year: 2008
The role of HER-2/neu, p53, Bcl-2 and Ki-67 in patients with lung cancer Source: International Congress 2019 – New molecular signatures in COPD, lung cancer and a1-antitrypsin deficiency Year: 2019
Expression of Fhit protein in non-small cell lung cancer (NSCLC) and its correlation with Ki-67, a proliferative marker Source: Eur Respir J 2002; 20: Suppl. 38, 230s Year: 2002
Accuracy of PD-L1 tumour staining of cytological and histological samples of lung adenocarcinoma Source: International Congress 2018 – Lung cancer: personalised medicine Year: 2018
The value of immunohistochemical markers in the differential diagnosis of adenocarcinomas Source: Annual Congress 2011 - Quality management for lung cancer patients Year: 2011
The expression of Ki-67, a marker of proliferative activity, in resected nonsmall cell lung cancer Source: Eur Respir J 2001; 18: Suppl. 33, 478s Year: 2001
Lung cancer surgery and prognostic fators: c-erb-2, Ki-67 and β-Hcg Source: Eur Respir J 2003; 22: Suppl. 45, 212s Year: 2003
Serum napsin A as a tumor marker for primary lung adenocarcinoma Source: Annual Congress 2010 - Biomarkers for lung cancer Year: 2010
MonoTotal vs. other cytokeratin markers in NSCLC Source: Annual Congress 2008 - Various aspects of thoracic oncology Year: 2008
Immunohistochemical expression of Hsp27 and alphaB-crystallin in different histological subtypes of lung cancer Source: Annual Congress 2012 - New aspects of lung cancer biology Year: 2012
Immunohistochemical studies of COX-2, MMP-9, p53 and VEGF in non-small-cell lung cancer, specifically squamous cell carcinoma and adenocarcinoma Source: Eur Respir J 2006; 28: Suppl. 50, 387s Year: 2006
Telomerase vs CD34 and MIB1 in non small cell lung cancer Source: Annual Congress 2008 - Biology and diagnosis of thoracic tumours Year: 2008
The value of HMBE-1, calretinin and cytokeratin5/6 for diagnosis of epitheloid malignant mesothelioma Source: Eur Respir J 2006; 28: Suppl. 50, 82s Year: 2006